Purchases and Sales Made in Q4 2024 in Eliem Therapeutics, Inc. (ELYM)
This table provides information about the institutional ownership of Eliem Therapeutics, Inc. (ELYM) during Q4 2024. The information is specifically focused on institutions that hold shares of Eliem Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 13, 2025
Q4 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 14, 2025
Q4 2024
|
Ikarian Capital, LLC
Dallas, TX |
SELL
|
- |
-12- 0.01% |
$49.3 - $65
|
175K
$720K
|
|
|
Feb 14, 2025
Q4 2024
|
Boothbay Fund Management, LLC
New York, NY |
SELL
|
- |
-12- 0.02% |
$49.3 - $65
|
53.7K
$221K
|
|
|
Feb 11, 2025
Q4 2024
|
American Century Companies Inc
Kansas City, MO |
SELL
|
- |
-201- 1.45% |
$826 - $1.09K
|
13.7K
$56.2K
|
|
|
Feb 14, 2025
Q4 2024
|
Manufacturers Life Insurance Company, The
Toronto, A6 |
SELL
|
- |
-10.6K- 21.45% |
$43.7K - $57.6K
|
38.9K
$160K
|
|
|
Feb 11, 2025
Q4 2024
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-18.6K- 1.22% |
$76.5K - $101K
|
1.51M
$6.19M
|
|
|
Feb 14, 2025
Q4 2024
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-43.9K- 6.53% |
$180K - $238K
|
629K
$2.58M
|
|
|
Feb 13, 2025
Q4 2024
|
Adar1 Capital Management, LLC
Austin, TX |
SELL
|
- |
-115K- 70.56% |
$474K - $625K
|
48.1K
$198K
|
|
|
Feb 14, 2025
Q4 2024
|
Janus Henderson Group PLC
London, X0 |
SELL
|
- |
-422K- 11.71% |
$1.74M - $2.29M
|
3.18M
$13.1M
|
|
|
Feb 14, 2025
Q4 2024
|
Ally Bridge Group (Ny) LLC
New York, NY |
SELL
|
- |
-469K- 38.16% |
$1.93M - $2.54M
|
760K
$3.12M
|
|
|
Feb 13, 2025
Q4 2024
|
Affinity Asset Advisors, LLC
New York, NY |
SELL
|
- |
-1M- 66.67% |
$4.11M - $5.42M
|
500K
$2.06M
|
|
|
Feb 14, 2025
Q4 2024
|
Deep Track Capital, LP
Greenwich, CT |
SELL
|
- |
-1.13M- 52.05% |
$4.64M - $6.12M
|
1.04M
$4.27M
|